Summary
- Current Price
- As of today, ANIP price is $79.88, up +0.86% on
- Current Price All-Time High
- ANIP price is currently -82.25% below its historical high of $450.00 set on
- Market Cap
- ANIP current market cap is $2B, up +26.87% over the past 365 days
- PE Ratio
- ANIP current PE ratio is 20.26
- Revenue
- ANIP current annual revenue is $883.37M, up +43.78% year-over-year
- Next Earnings
- The next earnings release for ANIP is on
Profile
| Metric | Value |
|---|---|
| Full Name | ANI Pharmaceuticals, Inc. |
| Ticker | NASDAQ: ANIP |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | anipharmaceuticals.com |
| Employees | 897 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $79.88 | |
| Price, 1D Change | +0.86% | |
| $2B | ||
| - | ||
| 20.26 | ||
| 0.37 | ||
| $883M | ||
| Revenue, 1Y Change | +43.78% | |
| $3.32 | ||
| EPS, 1Y Change | +418.76% |
Chart
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:6 | |
| Next Split | N/A | N/A |
| Last Ticker Change | BPAX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| $3.32 | ||
| EPS Estimate | N/A | $9.42 |
| EPS Est. Change | N/A | +183.39% |
| $883.37M | ||
| Revenue Estimate | N/A | $1.12B |
| Revenue Est. Change | N/A | +26.96% |
| Current Price | $79.88 | |
| Price Target | - | $110.00 |
| Price Tgt. Change | - | +37.71% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.28 | -$1.04 | -276.91% | |
| $7.52 | $3.32 | -55.80% | |
| $9.42 | N/A | +183.39% | |
| $10.76 | N/A | +223.66% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $599.19M | $614.38M | +2.53% | |
| $867.39M | $883.37M | +1.84% | |
| $1.12B | N/A | +26.96% | |
| $1.24B | N/A | +40.54% |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $79.88 | |
| $81.09 | ||
| $80.95 | ||
| $79.57 | ||
| $80.58 | ||
| -$0.53 | ||
| 0.37 | ||
| $2.32 | ||
| 48.15 | ||
| 25.35% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $1.16M | ||
| 1.62% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $883.37M | ||
| $3.32 | ||
| $450.64M | ||
| 51.01% | ||
| $81.23M | ||
| 9.20% | ||
| $71.37M | ||
| 8.08% | ||
| $172.65M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 1.16 | ||
| 2.71 | ||
| 2.19 | ||
| - | ||
| 8 | ||
| 2.38 |
Valuations
| Metric | Date | Value |
|---|---|---|
| 20.26 | ||
| 1.97 | ||
| 3.23 | ||
| 10.77 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $540.72M | ||
| $294.75M | ||
| $1.44B | ||
| $752.92M | ||
| $899.65M | ||
| $278.11M | ||
| $628.28M | ||
| $19.30M | ||
| $62.58M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $811.99M | ||
| $369.41M | ||
| $432.73M | ||
| $0.00 | ||
| $91.42M | ||
| $0.00 | ||
| $17.45M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| $185.23M | ||
| -$34.32M | ||
| -$9.94M | ||
| $34.32M | ||
| $150.90M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Canaccord Genuity | ||
| Guggenheim | → | |
| Guggenheim | → | |
| Barclays | ||
| Guggenheim | → | |
| Truist Securities | → | |
| JP Morgan | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| Truist Securities | → |
Analyst sentiment
Institutional ownership
Screeners with ANIP
FAQ
- What is the ticker symbol for ANI Pharmaceuticals, Inc.?
- The ticker symbol for ANI Pharmaceuticals, Inc. is NASDAQ:ANIP
- Does ANI Pharmaceuticals, Inc. pay dividends?
- No, ANI Pharmaceuticals, Inc. does not pay dividends
- What sector is ANI Pharmaceuticals, Inc. in?
- ANI Pharmaceuticals, Inc. is in the Healthcare sector
- What industry is ANI Pharmaceuticals, Inc. in?
- ANI Pharmaceuticals, Inc. is in the Specialty & Generic Drug Manufacturers industry
- What country is ANI Pharmaceuticals, Inc. based in?
- ANI Pharmaceuticals, Inc. is headquartered in United States
- When did ANI Pharmaceuticals, Inc. go public?
- ANI Pharmaceuticals, Inc. initial public offering (IPO) was on May 5, 2000
- Is ANI Pharmaceuticals, Inc. in the S&P 500?
- No, ANI Pharmaceuticals, Inc. is not included in the S&P 500 index
- Is ANI Pharmaceuticals, Inc. in the NASDAQ 100?
- No, ANI Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
- Is ANI Pharmaceuticals, Inc. in the Dow Jones?
- No, ANI Pharmaceuticals, Inc. is not included in the Dow Jones index
- When was ANI Pharmaceuticals, Inc. last earnings report?
- ANI Pharmaceuticals, Inc.'s most recent earnings report was on May 8, 2026
- When does ANI Pharmaceuticals, Inc. report earnings?
- The next expected earnings date for ANI Pharmaceuticals, Inc. is August 7, 2026
Data Sources & References
- ANIP Official Website www.anipharmaceuticals.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1023024/000102302426000014/0001023024-26-000014-index.htm
- ANIP Profile on Yahoo Finance finance.yahoo.com/quote/ANIP
- ANIP Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/anip
